NSE · LAXMIDENTL
Laxmi Dental Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹56 Cr with net profit ₹7 Cr — a 12.2% net margin, versus -3.9% the period before.
Shareholding
As of 2026-06-30
- Promoter41.8%
- Public17.21%
- FII30.1%
- DII10.89%
36,937 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 3.03× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #27 of 79 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,28,709 Cr | 243.12 | 13.58 | 20.48% | 7.7% |
| Max Healthcare Institute Ltd. | ₹1,08,487 Cr | 316.68 | 10.09 | 13.42% | 17.23% |
| Fortis Healthcare Ltd. | ₹72,061 Cr | 271.16 | 7.28 | 10.53% | 11.41% |
| Narayana Hrudayalaya Ltd. | ₹42,562 Cr | 188.99 | 9.38 | 17.76% | 10.2% |
| Aster DM Healthcare Ltd. | ₹42,465 Cr | 301.32 | 9.28 | 8.48% | 8.36% |
| Global Health Limited | ₹38,394 Cr | 266.42 | 9.69 | 14.05% | 12.62% |
| Krishna Institute of Medical Sciences Ltd. | ₹31,869 Cr | 751.37 | 14.18 | 10.74% | 6.18% |
| Dr. Lal Path Labs Ltd. | ₹31,553 Cr | 239.47 | 12.58 | 20.13% | 18.27% |
| Poly Medicure Ltd. | ₹16,957 Cr | 255.81 | 5.46 | 10.37% | 17.18% |
| Dr. Agarwal's Health Care Limited | ₹15,531 Cr | 391.96 | 7.66 | 6.58% | 6.4% |
| Laxmi Dental Limited(this company) | ₹1,186 Cr | 117.94 | 4.87 | 13.74% | 10.67% |
AI analysis
AI-generated · google/gemini-2.5-flashLaxmi Dental Limited is listed with a market capitalization of Rs 1232 Cr. The company reported revenue of Rs 242.45 Cr and a profit margin of 10.67%. Earnings per share (EPS) stood at Rs 6.08, while Return on Equity (ROE) was 13.74% and Return on Capital Employed (ROCE) was 14.03%. The debt-to-equity ratio is 0.28.
Positives
- +Revenue grew by 23.5%, indicating business expansion.
- +The debt-to-equity ratio is 0.28, suggesting a manageable debt level.
- +The company reported a profit margin of 10.67% and a positive EPS of Rs 6.08.
Negatives
- −Promoter holding decreased from 41.77% in Mar 2026 to 41.80% in June 2026, slightly above the previous general holding of 41.70% earlier than 2026.
- −Return on Capital Employed (ROCE) of 14.03% and Return on Equity (ROE) of 13.74% might be considered moderate.
- −The trailing PE ratio of 122.52 may indicate a high valuation relative to earnings.
Financial Performance
Laxmi Dental Limited recorded a revenue of Rs 242.45 Cr with a revenue growth of 23.5%. The company's net profit for the year ending Mar 2025 was Rs 31.77 Cr. Quarterly results show revenue increasing from Rs 61.66 Cr in Dec 2024 to Rs 73.95 Cr in Mar 2026, and net profit increasing from Rs 4.8 Cr to Rs 10.08 Cr in the same period.
Profitability & Returns
The company’s profit margin was 10.67%. It achieved a Return on Equity (ROE) of 13.74% and a Return on Capital Employed (ROCE) of 14.03%. Earnings per share (EPS) for the latest period was Rs 6.08. EBITDA for the year ending Mar 2025 was Rs 30.19 Cr.
Balance Sheet
Laxmi Dental Limited has a debt-to-equity ratio of 0.28, indicating a relatively low level of debt compared to its equity. The book value per share is Rs 44.27. No dividend yield was reported.
Ownership & Pledges
As of June 30, 2026, promoters held 41.80% of the company's shares. Foreign Institutional Investors (FIIs) held 30.10%, while Domestic Institutional Investors (DIIs) held 10.89%. Public shareholding was 17.21%. The company reported no pledged shares by promoters.
Shareholding Trend
Promoter holding has seen a slight increase from 41.70% in March 2025 to 41.80% in June 2026. FII holding has decreased from 34.24% in March 2025 to 30.10% in June 2026. DII holding remained relatively stable, fluctuating between 10.52% in March 2026 and 10.89% in June 2026.
Data as of — price: 2026-07-29 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.